Pharmaceutical
| Fri 10 Apr 2026
Geneva, April 10 -- Cogent Biosciences Inc has submitted a patent application for JAK2 V617F Inhibitors. This invention was developed by Bettendorf Tanna, Chatterjee Payal, Jalluri Ravi, Vine Logan E, Newhouse Bradley J, Fischer John P, Salituro Leah J, Alley Kimberly A, Carlson Paul R, Niman Scott W, Malinky Cori A, Trujillo Jo..